Literature DB >> 3290866

Neuroendocrine tumors of the gastrointestinal tract.

G Chejfec1, S Falkmer, U Askensten, L Grimelius, V E Gould.   

Abstract

Neoplastic proliferations of neuroendocrine cells (NE) may occur throughout the entire GI tract but affect particularly appendix and ileum ("midgut carcinoids"), rectum ("hindgut carcinoids"), as well as stomach and the duodenum ("foregut carcinoids"). Only more exceptionally, they arise in the esophagus, jejunum and colon. The NE tumors encompass a heterogeneous gross and microscopic structural spectrum, ranging from inconspicuous microproliferations ("mucous membrane nevi") to bulky tumor masses. Their growth patterns are usually characteristic and easily recognized. In doubtful cases their NE differentiation becomes established by a characteristic silver affinity, by the ultrastructurally observed presence of characteristic "endocrine" secretion granules, and by immunohistochemically detectable occurrence of "pan-NE markers" (neuron-specific enolase, chromogranins, and synaptophysin), biogenic amines (mainly serotonin), and neurohormonal peptides. Foregut carcinoids usually contain serotonin, gastrin, and somatostatin, midgut carcinoids often only serotonin and tachykinins, whereas the hindgut carcinoids as a rule are multihormonal with a wide spectrum of hormonal peptides, including even insulin. Most GI NE tumors are found in the appendix (50%) and the ileum (30%). Practically all (98%) of the appendiceal NE tumors are benign. They have recently been proposed as arising from apparently Schwann-cell-related NE cells in the submucosa, whereas the ileal--and probably also all the other non-appendiceal NE tumors--are derived from the totipotential cells in epithelial crypts of the mucosa. Among the ileal NE neoplasms a large number can metastasize and result in a fatal outcome. The ability to metastasize is related to the size and to the multiplicity of the primary tumors at the time of initial diagnosis and, to some extent, to their histopathologic growth pattern. Now, some relationship between the prognosis and the cytochemically assessed nuclear DNA content of the NE tumor cells has also been established; not less than about 1/4 to 1/3 seem to be aneuploid. Almost 90% of the rectal carcinoids are benign. Exceptionally, a highly malignant NE neoplasms can arise from the colon/rectum--as well as from the esophagus--composed of NE cells of small and intermediate size. The NE tumors of the stomach are often composed of ECL (enterochromaffin-cell-like) cells; such ECL cell carcinoids are related to atrophic gastritis with pernicious anemia; experimentally, they can be induced by hypergastrinemia in rats. Duodenal carcinoids often contain psammoma bodies and can be associated with neurofibromatosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3290866     DOI: 10.1016/S0344-0338(88)80042-6

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  14 in total

Review 1.  Mechanisms of storage and exocytosis in neuroendocrine tumors.

Authors:  Manfred Gratzl; Martin Breckner; Christian Prinz
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

2.  Small cell carcinoma of rectum: a case report.

Authors:  Enver Ihtiyar; Cem Algin; Serap Isiksoy; Ersin Ates
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

3.  Gastrointestinal carcinoids: characterization by site of origin and hormone production.

Authors:  M W Onaitis; P M Kirshbom; T Z Hayward; F J Quayle; J M Feldman; H F Seigler; D S Tyler
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

Review 4.  Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

Authors:  C Capella; P U Heitz; H Höfler; E Solcia; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Synchronous occurrence of early neuroendocrine carcinoma and tubular adenocarcinoma in the stomach.

Authors:  Yoshifumi Nakayama; Aiichirou Higure; Kazunori Shibao; Nagahiro Sato; Nobutaka Matayoshi; Koji Yamaguchi
Journal:  Clin J Gastroenterol       Date:  2012-07-18

6.  Amphicrine tumor.

Authors:  L Mándoky
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

7.  Prognostic criteria in nonfunctioning pancreatic endocrine tumours.

Authors:  S La Rosa; F Sessa; C Capella; C Riva; B E Leone; C Klersy; G Rindi; E Solcia
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

8.  Small cell carcinoma in ulcerative colitis--new treatment option: a case report.

Authors:  Christoforos Kosmidis; Christoforos Efthimiadis; Georgios Anthimidis; Kalliopi Vasiliadou; Ioanna Tzeveleki; Panagiotis Fotiadis; Georgios Basdanis
Journal:  World J Surg Oncol       Date:  2010-11-18       Impact factor: 2.754

9.  Anorectal carcinoid tumors. Is aggressive surgery warranted?

Authors:  P Sauven; J A Ridge; S H Quan; E R Sigurdson
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

10.  Synchronous occurrence of advanced neuroendocrine carcinoma and tubular adenocarcinoma of the rectum.

Authors:  Yoshifumi Nakayama; Takayuki Torigoe; Noritaka Minagawa; Toshihito Uehara; Koji Yamaguchi
Journal:  Case Rep Gastroenterol       Date:  2013-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.